Special Issue "Personalized Care for HIV Prevention, Treatment and Cure"
Deadline for manuscript submissions: closed (5 July 2022) | Viewed by 23889
Interests: HIV infection; HIV management; HIV prevention; e-Health; patient-oriented research; patient-reported outcome measures
Globally, great strides have been made in HIV testing and treatment over the last 30 years, which has helped to transform HIV from a fatal disease into a chronic, manageable condition for many people. However, HIV infection continues to pose a critical risk to health in many countries. The management of HIV can benefit from more individualized care and newer treatment options. Personalized medicine (PM) has the potential to tailor prevention and care interventions to optimize safety, effectiveness and patient satisfaction. By tailoring interventions to patient needs and characteristics (e.g., lifestyle, environment, genetics), chronic disease management goals are achieved. Researchers are actively seeking new personalized approaches to prevent, treat, and ultimately cure HIV infection.
This Special Issue of the Journal of Personalized Medicine is focused on describing current personalized medicine approaches to HIV care. This encompasses efforts to deliver individualized care using modern technologies and innovative care models for HIV prevention, comorbidities (hepatitis C, cardiovascular, neurocognitive decline, etc.) and treatment so as to improve the length and quality of life of HIV/AIDS patients.
This Special Issue will bring together cutting-edge research across disciplines, including the basic sciences, clinical care and the behavioral and social sciences, in order to better understand and intervene to the benefit of people living with HIV.
The aim of this Special Issue is to collate evidence-based manuscripts on relevant topics in the field. Research articles, clinical studies, quantitative and qualitative analyses of pilot studies, meta-analyses, and reviews are all welcome.
Dr. Bertrand Lebouche
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- HIV infection
- HIV prevention
- HIV care
- HIV cure
- Antiretroviral therapy